Kobayashi Pharmaceutical Co., Ltd. (TYO: 4967)

Market Cap	395.04B
Revenue (ttm)	168.80B
Net Income (ttm)	10.18B
Shares Out	74.34M
EPS (ttm)	136.67
PE Ratio	38.88
Forward PE	25.04
Dividend	101.00 (1.93%)
Ex-Dividend Date	Dec 27, 2024

Volume	444,900
Open	5,250.00
Previous Close	5,220.00
Day's Range	5,221.00 - 5,333.00
52-Week Range	4,700.00 - 7,050.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company offers Ammeltz, a topical analgesic; Bluelet Decoral, a toilet bowl cleaner and freshener; Shoshugen, air freshener; Inochi no Haha, a women’s health medicine; Eyebon, an eye wash; Sarasaty lingerie soap; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet for forehead; Sawaday, a toi...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1886
• Employees: 3,534
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4967

Financial Performance

In 2023, Kobayashi Pharmaceutical's revenue was 173.46 billion, an increase of 4.33% compared to the previous year's 166.26 billion. Earnings were 20.34 billion, an increase of 1.58%.